[PAR] YoY Quarter Result on 30-Jun-2021 [#Q4]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
29-Jun-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q4]
Profit Trend
QoQ- 34.55%
YoY- -88.56%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 66 42 34 21 -826 2,956 2,660 -45.96%
PBT -14,681 -26,309 -12,265 -13,567 -7,195 -11,227 -2,617 33.26%
Tax -4,986 -6,266 -0 0 -826 2,956 0 -
NP -9,695 -20,043 -12,265 -13,567 -7,195 -11,227 -2,617 24.36%
Tax Rate - - - - - - - -
Total Cost 9,761 20,085 12,299 13,587 6,369 14,183 5,277 10.78%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -14,733.74 -47,663.70 -36,046.75 -66,017.95 871.10 -379.84 -98.38 130.26%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.03 -0.07 -0.05 -0.06 -0.03 -0.08 -0.02 6.98%
EPS Diluted -0.03 -0.07 -0.05 -0.06 -0.03 -0.08 -0.02 6.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.